Visión generalGráficoNoticiasTraderScreen

Soc. Generale Knock-Out WM/  DE000SU8A2D6  /

Frankfurt Zert./SG
28/05/2024  13:36:37 Diferencia+0.090 Bid13:43:10 Ask13:43:10 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
1.560EUR +6.12% 1.560
Volumen de oferta: 2,000		 1.650
Tamaño/ Volumen/ Formato de Ask: 2,000		 Waste Management 191.957 USD 31/12/2078 Call
TeleTrader 13:47 Ireland, Norway formally recognize Palestine as state
GlobeNewswire 13:45 NeuralAI Launches AI 3D Asset Generator with TAO Bittensor Subnet: Transforming 3D Model Creation fo...
GlobeNewswire 13:37 CAE, INC. ALERT: CAE, Inc. Falls after Announcing Impairment Charges (NYSE: CAE) – Investors are Enc...
GlobeNewswire 13:35 Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey ...
GlobeNewswire 13:33 Inter&Co doubles down on SMEs through acquisition of Granito
GlobeNewswire 13:32 WIDEOPENWEST ALERT: WideOpenWest’s $4.80 Per Share Offer from DigitalBridge is Under Investigation (...
GlobeNewswire 13:31 SQUARESPACE ALERT: Squarespace’s $44 Per Share Buyout Offer From Permira is Under Investigation (NYS...
TeleTrader 13:30 IAEA: Impossible to restart Zaporizhzhia nuclear plant
Newsfile Corp 13:30 RE Royalties Ltd. to Present at Canadian Climate Investor Conference
GlobeNewswire 13:30 Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwri...
GlobeNewswire 13:30 KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
GlobeNewswire 13:30 Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director ...
GlobeNewswire 13:30 Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire 13:30 Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
GlobeNewswire 13:30 Judge Consulting Recognized on 2024 CRN Solution Provider 500 List
GlobeNewswire 13:30 TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire 13:30 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 13:30 Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
GlobeNewswire 13:30 Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 13:30 Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
GlobeNewswire 13:26 LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before...
GlobeNewswire 13:26 CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: C...
GlobeNewswire 13:24 Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
TeleTrader 13:13 Altman in new safety, security committee created by OpenAI
GlobeNewswire 13:10 Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million